| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Protagenic Therapeutics Inc (NASDAQ: PTIX)
PTIX Technical Analysis
2.5
| As on 12th Dec 2025 PTIX SHARE Price closed @ 1.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.08 & Strong Buy for SHORT-TERM with Stoploss of 0.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PTIXSHARE Price
| Open | 1.56 | Change | Price | % |
| High | 1.68 | 1 Day | 0.07 | 4.43 |
| Low | 1.55 | 1 Week | -0.15 | -8.33 |
| Close | 1.65 | 1 Month | -0.82 | -33.20 |
| Volume | 112850 | 1 Year | 1.06 | 179.66 |
| 52 Week High 11.10 | 52 Week Low 0.20 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OCG | 0.22 | -75.82% |
| NVDA | 175.02 | -3.27% |
| CGC | 1.74 | 53.98% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.32 | -1.69% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PTIX Daily Charts |
PTIX Intraday Charts |
Whats New @ Bazaartrend |
PTIX Free Analysis |
|
|
PTIX Important Levels Intraday
| RESISTANCE | 1.90 |
| RESISTANCE | 1.82 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.72 |
| SUPPORT | 1.58 |
| SUPPORT | 1.53 |
| SUPPORT | 1.48 |
| SUPPORT | 1.40 |
PTIX Forecast December 2025
| 4th UP Forecast | 2.5 |
| 3rd UP Forecast | 2.23 |
| 2nd UP Forecast | 2.06 |
| 1st UP Forecast | 1.89 |
| 1st DOWN Forecast | 1.41 |
| 2nd DOWN Forecast | 1.24 |
| 3rd DOWN Forecast | 1.07 |
| 4th DOWN Forecast | 0.8 |
PTIX Weekly Forecast
| 4th UP Forecast | 1.80 |
| 3rd UP Forecast | 1.75 |
| 2nd UP Forecast | 1.72 |
| 1st UP Forecast | 1.69 |
| 1st DOWN Forecast | 1.61 |
| 2nd DOWN Forecast | 1.58 |
| 3rd DOWN Forecast | 1.55 |
| 4th DOWN Forecast | 1.50 |
PTIX Forecast2025
| 4th UP Forecast | 28.82 |
| 3rd UP Forecast | 20.11 |
| 2nd UP Forecast | 14.72 |
| 1st UP Forecast | 9.33 |
| 1st DOWN Forecast | -6.03 |
| 2nd DOWN Forecast | -11.42 |
| 3rd DOWN Forecast | -16.81 |
| 4th DOWN Forecast | -25.52 |
Protagenic Therapeutics Inc ( NASDAQ USA Symbol : PTIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PTIX Business Profile
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York. Address: 149 Fifth Avenue, New York, NY, United States, 10010
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service